Zhang F - Search Results

1

Self-assembled aldehyde dehydrogenase-activatable nano-prodrug for cancer stem cell-enriched tumor detection and treatment.

Li B, Tian J, Zhang F, Wu C, Li Z, Wang D, Zhuang J, Chen S, Song W, Tang Y, Ping Y, Liu B. Li B, et al. Among authors: zhang f. Nat Commun. 2024 Oct 31;15(1):9417. doi: 10.1038/s41467-024-53771-8. Nat Commun. 2024. PMID: 39482286 Free PMC article.

2

Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma.

Wu L, Zhang F, Chen X, Wan J, Wang Y, Li T, Wang H. Wu L, et al. Among authors: zhang f. ACS Appl Mater Interfaces. 2020 Jan 22;12(3):3327-3340. doi: 10.1021/acsami.9b16209. Epub 2020 Jan 7. ACS Appl Mater Interfaces. 2020. PMID: 31872760

3

Delivery of a system x_c^- inhibitor by a redox-responsive levodopa prodrug nanoassembly for combination ferrotherapy.

Xin H, Huang Y, Tang H, Chen Y, Xia H, Zhang F, Li B, Ping Y. Xin H, et al. Among authors: zhang f. J Mater Chem B. 2021 Sep 15;9(35):7172-7181. doi: 10.1039/d1tb00742d. J Mater Chem B. 2021. PMID: 34369535

4

Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Wang M, Hu Q, Huang J, Zhao X, Shao S, Zhang F, Yao Z, Ping Y, Liang T. Wang M, et al. Among authors: zhang f. J Nanobiotechnology. 2022 Feb 17;20(1):85. doi: 10.1186/s12951-022-01282-3. J Nanobiotechnology. 2022. PMID: 35177078 Free PMC article.

5

Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma.

Tang H, Xue Y, Li B, Xu X, Zhang F, Guo J, Li Q, Yuan T, Chen Y, Pan Y, Ping Y, Li D. Tang H, et al. Among authors: zhang f. Acta Pharm Sin B. 2022 Aug;12(8):3410-3426. doi: 10.1016/j.apsb.2022.02.007. Epub 2022 Feb 14. Acta Pharm Sin B. 2022. PMID: 35967289 Free PMC article.

6

A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.

Zhang F, Hu Q, Li B, Huang Y, Wang M, Shao S, Tang H, Yao Z, Ping Y, Liang T. Zhang F, et al. J Control Release. 2023 Feb;354:835-850. doi: 10.1016/j.jconrel.2023.01.007. Epub 2023 Jan 30. J Control Release. 2023. PMID: 36627026

7

A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.

Chen Y, Yao Z, Liu P, Hu Q, Huang Y, Ping L, Zhang F, Tang H, Wan T, Ping Y, Li B. Chen Y, et al. Among authors: zhang f. Acta Biomater. 2023 Mar 15;159:275-288. doi: 10.1016/j.actbio.2023.01.050. Epub 2023 Jan 26. Acta Biomater. 2023. PMID: 36709836

8

A Self-Assembly Nano-Prodrug for Combination Therapy in Triple-Negative Breast Cancer Stem Cells.

Wu C, Zhang F, Li B, Li Z, Xie X, Huang Y, Yao Z, Chen Y, Ping Y, Pan W. Wu C, et al. Among authors: zhang f. Small. 2023 Oct;19(41):e2301600. doi: 10.1002/smll.202301600. Epub 2023 Jun 16. Small. 2023. PMID: 37328445

9

Tumor-overexpressed enzyme responsive amphiphiles small molecular self-assembly nano-prodrug for the chemo-phototherapy against non-small-cell lung cancer.

Liu P, Huang Y, Zhan C, Zhang F, Deng C, Jia Y, Wan T, Wang S, Li B. Liu P, et al. Among authors: zhang f. Mater Today Bio. 2023 Jul 4;21:100722. doi: 10.1016/j.mtbio.2023.100722. eCollection 2023 Aug. Mater Today Bio. 2023. PMID: 37545562 Free PMC article.

10

Activatable Type I Photosensitizer with Quenched Photosensitization Pre and Post Photodynamic Therapy.

Tian J, Li B, Zhang F, Yao Z, Song W, Tang Y, Ping Y, Liu B. Tian J, et al. Among authors: zhang f. Angew Chem Int Ed Engl. 2023 Nov 13;62(46):e202307288. doi: 10.1002/anie.202307288. Epub 2023 Oct 9. Angew Chem Int Ed Engl. 2023. PMID: 37681940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,800 results

Search Page

Filters